R87.614ActuelleCode facturable et spécifique

Cytologic evidence of malignancy on smear of cervix

R83-R89 · Instructions des niveaux supérieurs

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

R87.61 · Instructions des niveaux supérieurs

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes 2 · 9

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87.61 · Abnormal cytological findings in specimens from cervix uteri

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Facturation et couverture

La couverture dépend du payeur, du service et de la politique applicable. Un code facturable ne garantit pas le paiement.

Quand ICD-10-CM est obligatoire

Pour les demandes de remboursement américaines soumises à HIPAA, ICD-10-CM est obligatoire pour les diagnostics depuis le 1er octobre 2015.

Utilisez la date des soins en ambulatoire et pour les actes professionnels, et la date de sortie pour les séjours hospitaliers. Les soins antérieurs relèvent d’ICD-9-CM ; chaque code doit aussi être valable à la date concernée.

Directives officielles de codage → · CMS ↗

MS-DRG · 43.1 · 742, 743, 760, 761

Le groupage dépend du dossier complet et des règles CMS.

742 · Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC
743 · Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC
760 · Menstrual and Other Female Reproductive System Disorders with CC/MCC
761 · Menstrual and Other Female Reproductive System Disorders without CC/MCC

2026-04-01 – 2026-09-30

CMS · MS-DRG 43.1

Vérifier la couverture Medicare ↗

Première observation · 2015-10-01

Historique du code

Aucune modification depuis la première observation

ModifiéInchangé

FY2016

En vigueur dès le 2015-10-01

Première observation

Cytologic evidence of malignancy on smear of cervix

Code de diagnostic facturable

CDC/NCHS · FY2016

Toutes les éditions (19)

Toutes les éditions	En vigueur dès le	Historique du code
FY2016	2015-10-01	Première observation
FY2017	2016-10-01	Aucun changement tabulaire
FY2018	2017-10-01	Aucun changement tabulaire
FY2019	2018-10-01	Aucun changement tabulaire
FY2020	2019-10-01	Aucun changement tabulaire
FY2020 · April	2020-04-01	Aucun changement tabulaire
FY2021	2020-10-01	Aucun changement tabulaire
FY2021 · 01-01	2021-01-01	Aucun changement tabulaire
FY2022	2021-10-01	Aucun changement tabulaire
FY2022 · 04-01	2022-04-01	Aucun changement tabulaire
FY2023	2022-10-01	Aucun changement tabulaire
FY2023 · 04-01	2023-04-01	Aucun changement tabulaire
FY2024	2023-10-01	Aucun changement tabulaire
FY2024 · 04-01	2024-04-01	Aucun changement tabulaire
FY2025	2024-10-01	Aucun changement tabulaire
FY2025 · 04-01	2025-04-01	Aucun changement tabulaire
FY2026	2025-10-01	Aucun changement tabulaire
FY2026 · April	2026-04-01	Aucun changement tabulaire
FY2027	2026-10-01	Aucun changement tabulaire

Correspondances ICD-9 historiques · 2018

Correspondance historique uniquement ; pas de substitution automatique.

795.06

CDC/NCHS · GEM 2018

Instructions du code

La liste tabulaire officielle ne comporte pas d’instructions supplémentaires à ce niveau du code.

Consultez ci-dessous les instructions héritées des catégories parentes. Instructions des niveaux supérieurs ↓

Consulter les directives officielles de codage ↗

Instructions des niveaux supérieurs

Chapitres 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

R87.61 · Abnormal cytological findings in specimens from cervix uteri

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Références de l’index officiel (2)

Abnormal, abnormality, abnormalities (1)

Abnormal, abnormality, abnormalities › Papanicolaou(smear) › cervix › cytologic evidence of malignancyIndex des maladies

Evidence (1)

Evidence › cytologic › of malignancy on cervical smearIndex des maladies

Codes associés

Autres entrées de la même catégorie ; elles ne sont pas des substituts automatiques.

Code	Description	Catégorie · précision supplémentaire requise
R87.610	Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)	Code facturable et spécifique
R87.611	Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)	Code facturable et spécifique
R87.612	Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)	Code facturable et spécifique
R87.613	High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)	Code facturable et spécifique
R87.615	Unsatisfactory cytologic smear of cervix	Code facturable et spécifique
R87.616	Satisfactory cervical smear but lacking transformation zone	Code facturable et spécifique
R87.618	Other abnormal cytological findings on specimens from cervix uteri	Code facturable et spécifique
R87.619	Unspecified abnormal cytological findings in specimens from cervix uteri	Code facturable et spécifique

Les intitulés et instructions officiels sont conservés dans la langue source. Sources officielles ↗

R87.61 · Instructions des niveaux supérieurs

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Facturation et couverture

La couverture dépend du payeur, du service et de la politique applicable. Un code facturable ne garantit pas le paiement.

Quand ICD-10-CM est obligatoire

Pour les demandes de remboursement américaines soumises à HIPAA, ICD-10-CM est obligatoire pour les diagnostics depuis le 1er octobre 2015.

Directives officielles de codage → · CMS ↗

MS-DRG · 43.1 · 742, 743, 760, 761

Le groupage dépend du dossier complet et des règles CMS.

742 · Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC
743 · Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC
760 · Menstrual and Other Female Reproductive System Disorders with CC/MCC
761 · Menstrual and Other Female Reproductive System Disorders without CC/MCC

2026-04-01 – 2026-09-30

CMS · MS-DRG 43.1

Vérifier la couverture Medicare ↗

Toutes les éditions

En vigueur dès le

Historique du code

FY2016

2015-10-01

Première observation

FY2017

2016-10-01

Aucun changement tabulaire

FY2018

2017-10-01

Aucun changement tabulaire

FY2019

2018-10-01

Aucun changement tabulaire

FY2020

2019-10-01

Aucun changement tabulaire

FY2020 · April

2020-04-01

Aucun changement tabulaire

FY2021

2020-10-01

Aucun changement tabulaire

FY2021 · 01-01

2021-01-01

Aucun changement tabulaire

FY2022

2021-10-01

Aucun changement tabulaire

FY2022 · 04-01

2022-04-01

Aucun changement tabulaire

FY2023

2022-10-01

Aucun changement tabulaire

FY2023 · 04-01

2023-04-01

Aucun changement tabulaire

FY2024

2023-10-01

Aucun changement tabulaire

FY2024 · 04-01

2024-04-01

Aucun changement tabulaire

FY2025

2024-10-01

Aucun changement tabulaire

FY2025 · 04-01

2025-04-01

Aucun changement tabulaire

FY2026

2025-10-01

Aucun changement tabulaire

FY2026 · April

2026-04-01

Aucun changement tabulaire

FY2027

2026-10-01

Aucun changement tabulaire